Clinical trials - 1 News by ITM Isotopen Technologien München
Precise attack on tumor remnants
Targeting brain tumors: new drug candidate in clinical trial
15-Mar-2023 - Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the radiopharmaceutical company ITM Isotope Technologies Munich and Münster University Hospital, ...
Haven't found the right news yet?
The bionity.com news search
Start your targeted search now with a wide range of filter options. Our database includes an archive of 25,063 life science news from business and science, which you can search by topic and organization, filtered by time and geography.